Compatibility and Safety Implications Associated with Interfacing Medical Devices in Neonatal Respiratory Care: A Case Example Using the Inhaled Nitric Oxide Delivery System
- PMID: 33628066
- PMCID: PMC7899041
- DOI: 10.2147/MDER.S268477
Compatibility and Safety Implications Associated with Interfacing Medical Devices in Neonatal Respiratory Care: A Case Example Using the Inhaled Nitric Oxide Delivery System
Abstract
Over the past decade, international organizations have instituted strict regulations for the safe use of connected medical devices. The International Organization for Standardization and the Medical Device Single Audit Program instituted certifications to ensure that connected devices are compatible and operate within their proper clinical parameters. These efforts came about, in part, as a consequence of clinicians' decisions to use nonstandard, modified, or improvised devices for purposes outside the original manufacturers' approved parameters. Unapproved device modifications can be associated with increased risk of dosing errors, monitoring errors, tubing misconnections and serious or potentially fatal adverse events; furthermore, health care providers who implement unapproved device modifications may assume legal and financial liability should harm come to patients as a consequence of the modification. Using the inhaled nitric oxide delivery system as an example, the objective of this paper is to raise awareness of the potential dangers associated with unapproved modification and interfacing of therapeutic gas delivery systems and ventilators in the neonatal intensive care unit setting. The paper also highlights the rationale and necessity for rigorous validation processes that ensure that interfaced medical devices perform as intended in the clinical setting.
Keywords: equipment failure; medical device legislation; patient safety.
© 2021 DeWitt et al.
Conflict of interest statement
Anthony L. DeWitt has received no compensation. Jaron Acker is an employee of Mallinckrodt Pharmaceuticals and may hold stock or stock options in that company; at the time the study was completed, he was part of Mallinckrodt's Medical Device Engineering Department. Thomas A. Larkin is an employee of Mallinckrodt Pharmaceuticals. Jim L. Potenziano is a former employee of Mallinckrodt Pharmaceuticals and holds stock in that company. Jeffrey M. Schmidt is a former employee of Mallinckrodt Pharmaceuticals. The authors report no other conflicts of interest in this work.
Figures

Similar articles
-
Materials vigilance and traceability.Orthop Traumatol Surg Res. 2016 Feb;102(1 Suppl):S95-103. doi: 10.1016/j.otsr.2015.05.013. Epub 2016 Jan 25. Orthop Traumatol Surg Res. 2016. PMID: 26822532 Review.
-
Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.Hosp Technol Ser. 1993 Oct;12(11):1-27. Hosp Technol Ser. 1993. PMID: 10129209
-
Enteral feeding misconnections in the NICU: a continuing patient safety threat.Adv Neonatal Care. 2013 Dec;13(6):447-53. doi: 10.1097/ANC.0000000000000032. Adv Neonatal Care. 2013. PMID: 24300965 Review.
-
Inhaled nitric oxide: technical aspects of administration and monitoring.Crit Care Med. 1998 Apr;26(4):782-96. doi: 10.1097/00003246-199804000-00033. Crit Care Med. 1998. PMID: 9559620 Review.
-
[Medical devices and patient safety from the clinicians' view].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Jun;52(6):584-8. doi: 10.1007/s00103-009-0855-z. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009. PMID: 19436959 German.
References
-
- British Standards Institution. Medical Devices - Quality Management Systems - Requirements for Regulatory Purposes (ISO 13485:2016). London, United Kingdom: British Standards Institution; 2017.
-
- Guidance document for premarket notification submissions for nitric oxide delivery apparatus, nitric oxide analyzer and nitrogen dioxide analyzer. Food and Drug Administration website; 2000. Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/.... Accessed November25, 2019.
-
- Medical Device Single Audit Program: Frequently Asked Questions; 2017. Available from: https://www.fda.gov/downloads/medicaldevices/internationalprograms/mdsap.... Accessed: February13, 2019.
-
- Medical Device Single Audit Program (MDSAP); 2018. Available from: https://www.fda.gov/medicaldevices/internationalprograms/mdsappilot/. Accessed February13, 2019.
-
- Laaperi v. Sears, Roebuck & Co., Inc. 787 F.2d 726. 1986.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous